#nuclear medicine trends
Text
Global Nuclear Medicine Therapeutics Market: Pioneering Healthcare Solutions
A pharmaceutical composition including radioactive elements is known as therapeutic nuclear medicine. In comparison to X-rays and other external radiation imaging technologies, therapeutic nuclear medicines are widely employed as an effective and safer alternative for cancer patients.
Market Size & Growth Rate:
The nuclear medicine therapeutics market was valued at USD 1 billion in 2021 and is expected to reach USD 1.8 billion by 2027, exhibiting a CAGR of 9.6% during the forecast period 2022-2027. The growth could be attributed to the return of demand to pre-pandemic levels, increasing authorization of novel & innovative medicines, extensive research, disease prevalence, and immunotherapies.
Market Dynamics:
According to the oncidium foundation, nuclear-therapy accounted for 20% of the global nuclear medicine market in 2019 and is expected to reach 70% by 2030. Nuclear therapeutic is majorly used for the treatment & diagnosis of Cardiovascular Disease (CVD) and cancers. According to WHO-2021, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. The prevalence of these markets has promoted several market players and stakeholders to focus on expanding the overall application of radio-therapeutics. With the expanding application segments of nucleo-emitters, their demand and anticipated rising during the forecast period. It indicates to market players for growth of the nuclear medicine therapeutics market. In addition, various R&D activities in the business space are expected to stimulate the demand for therapeutic nuclear medicine through 2029. For instance,
Click here for full report:
https://www.pharmanucleus.com/reports/nuclear-medicine-therapeutics
Click here for Free Sample:
https://www.pharmanucleus.com/request-sample/1165
Based on the radionuclide therapeutic type, the beta emitters segment grow at a considerable pace during the forecast period. These beta particles like Samarium-153 (SM-153), Iodine-131 (I-131), and Lutetium-177 (LU-177) are known to be lighter than alpha particles like Radium-224 (RA-224), Radium-223 (RA-223) and can penetrate the skin easily
Get more details on this report - Request Free Sample
According to precedence research, by application, the oncology segment accounted major market share of around 40% in 2021 followed by cardiology.
Market Drivers:
Click here for full report:
https://www.pharmanucleus.com/reports/nuclear-medicine-therapeutics
The market players are focusing on various research developments, product launches, and acquisitions that are anticipated to increase the market growth. For instance,
Challenges:
#nuclear medicine#therapeutics#healthcare solutions#radiopharmaceuticals#medical innovation#patient care#nuclear medicine trends#advanced treatments#healthcare breakthroughs#cutting-edge therapies#global market insights
0 notes
Text
Radiopharmaceuticals in Nuclear Medicine Market Market Overview,Market Key Trends
The global Radiopharmaceuticals In Nuclear Medicine Market is estimated to reach a value of US$ 11,978.6 Mn or Mn by 2022, exhibiting a steady compound annual growth rate (CAGR) of 8.0% over the forecast period of 2020-2027
#Radiopharmaceuticals In Nuclear Medicine Market Overview#Radiopharmaceuticals In Nuclear Medicine Market Key Trends#Radiopharmaceuticals In Nuclear Medicine Market Size#Radiopharmaceuticals In Nuclear Medicine Market Growth#Radiopharmaceuticals In Nuclear Medicine Market .
0 notes
Text
#Nuclear Medicine Market#Nuclear Medicine Market size#Nuclear Medicine Market share#Nuclear Medicine Market trends#Nuclear Medicine Market analysis#Nuclear Medicine Market forecast#Nuclear Medicine Market outlook
1 note
·
View note
Text
Periodic Table Championship:
Round 2, Day 3, Plutonium vs. Bismuth
Match 6 of day 3 of round 2 of the championship has element 94, plutonium, facing off against element 83, bismuth. Last round, plutonium and bismuth won with similar margins, with plutonium beating scandium with 67.7% of the votes, and bismuth beating selenium with 63.4% of the votes. A reminder of our challengers:
Plutonium is hard, radioactive actinide element that crystalizes in the monoclinic crystal structure at room temperature. It is the element with the highest atomic number to be found in nature. Plutonium primarily has applications in explosives and nuclear fuel. It was named for the (former) planet Pluto, following the trend of uranium and neptunium.
Bismuth is a brittle post-transition metal that crystalizes in the rhombehedral crystal system at room temperature. It is well known for its ability to form iridescent, spiral crystals. Bismuth has applications in medicine, cosmetics, and alloying, sometimes as a replacement for lead. The origin of its name is uncertain.
6 notes
·
View notes
Text
(Inspired vaguely by @slatestarscratchpad's Columbian Exchange)
Ephemero: Excuse me, sir? Could you step aside for a second? I'm here to take down that statue and you're blocking my access.
Permanento: Never!
Ephemero: Hey, I'm just doing my job here!
Permanento: I don't care! City hall is really letting a few activists pressure them in removing the statue of general Nyrkoson, who lost his life guarding our borders from the Yorvardian invasion?
Ephemero: Well, if you're going to make this about his actions, he also killed and tortured prisoners, sent Yorvardian war orphans off to foreign lands for adoption, and popularized the use of nerve gas. Back when they built this statue nobody might have minded, but today we're enlightened enough to reject those actions, and the man who perpetuated them!
Permanento: Oh, sure, by our modern standards general Nyrkoson isn't a great person, but it's not about that! Statues aren't supposed to be an endorsement and display of those heroes who we still revere today! Statues are a way to trick rational egomaniacs into serving the common cause!
Ephemero: What? I thought you were going to make an argument about judging people by 'the values of their time', but this doesn't quite sound like it. Carry on?
Permanento: There's a group of people - a pretty large group, actually - that just doesn't care about others, won't lift a finger to help them, just cares about their own sense of greatness and importance. So society says, 'hey, if you are a prosocial champion of our values, if you make sacrifices to advance them, and accomplish great things, then we'll give you a statue to honor your deeds into the far future'. There's other stuff to it too, but let's use the statue as a symbol for now. And know what, it works! Off the egoists go to cure disease, right wrongs, even give their own lives: all for the chance at eternal heroism. If we start knocking down statues, we're changing the bargain to 'advance our values and we shall honor you until those values cease to appeal to us': that's a much worse deal!
Ephemero: Is it? Sure, you're getting fewer glory-seeking heroes, but you're getting better ones, right?
Permanento: Elaborate?
Ephemero: Well, imagine the 1800s. From your own, modern perspective, would you want the honored heroes of the 1800s to be its greatest doctors, or its greatest politicians?
Permanento: I'd imagine the doctors hold up a bit better? I like medicine, but a lot of 1800s politicians were pretty racist. I have no trouble admitting that, just as I'm fine with admitting Nyrkoson shouldn't get honored if he lived today.
Ephemero: Exactly! And people in the 1800s could have figured that out! They know that political trends come and go, but pretty much every society honors great medical achievements! But under your system, the egomaniacs don't really care: as long as they get a statue before their politics get too outdated, they're good! On the other hand, if their accomplishments must be justified to all future civilizations, then the medical track looks a lot better all of a sudden. We would still encourage greatness: just the greatness we like best!
Permanento: Now hold on! In the present day, that means people won't support present-day values: they will support the values of the society they imagine to be dominant for the coming centuries. I want heroes to serve our values, not those of their imaginary future-dwellers!
Ephemero: Well, predicting the future is hard, so they'll probably look at current-day causes that are steadily growing in support, or all-time success stories. Certainly, nobody who wants to become one of posterity's heroes would serve causes dwindling in popularity, like homophobia!
Permanento: Or nuclear power?
Ephemero: Fair; I am assuming that on the whole, society is getting more correct on the big issues over time. But even if we aren't, and norms never neatly converge on truth, that's just more reason to stick with the all-time favorites: feeding the hungry, sheltering the homeless, curing the sick!
Permanento: Well, that's a very interesting philosophy, but there's one thing you haven't thought about, and it poses a major problem.
Ephemero: Which is?
Permanento: If you ever spread this philosophy far enough: enough for it to become an actual widespread ideal, enough for a public debate to start along the same lines as mine and yours, arguing whether or not statues should stand forever...
Ephemero: Oh.
Permanento: ...what side do you think all the driven, glory-obsessed egomaniacs will flock to support?
Ephemero: "I'm still going to need to take Nyrkoson down."
Permanento: "No can do: I'm hoping this bullheaded resistance get me immortalized by future statue-lovers."
#only mildly related to ongoing discourses#a joke first and foremost#acausal bargains#idk who uses that tag and i am not going to find out
3 notes
·
View notes
Text
Beyond Borders: The Global Molybdenum-99 Market Offers Hope for Millions
The global molybdenum-99 market is on track for significant growth, with a projected value of US$7.28 billion by 2033 according to a recent forecast by Future Market Insights (FMI). This represents a Compound Annual Growth Rate (CAGR) of 5.0% from 2023. Mo-99 remains one of the most widely used radioisotopes in nuclear medicine diagnostic procedures.
Medical practitioners from all around the world use nuclear medicine imaging techniques to see the anatomy and function of a tissue, organ, or system in the body. The healthcare industry needs to provide better technologies to aid in the accurate and timely detection of life-threatening illnesses. As a result, processes for making molybdenum have been found.
Unveil Trends: Secure Your Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12424
In recent years, there has been a shift in the production of Mo-99 from reactors to sources of enriched uranium. The demand for improved safety and supply reliability, along with better cost-effectiveness and production efficiency, has driven this. Consequently, enterprises are currently producing Mo-99 using enriched uranium sources, like molybdenum-enriched uranium targets, creating new markets for the isotope.
Key Takeaways
● By 2033, the United States is likely to dominate the molybdenum-99 market, with a size of US$ 3,103.4 million.
● The molybdenum-99 market was significantly expanding, with a size of US$ 4.25 billion in 2022.
● There is a market opportunity of US$ 253 million in absolute terms, which is driven by the need to manage the non-communicable disease.
● The expansion in China is anticipated to expand at an adequate CAGR of 7.7% by 2033.
● By 2033, Germany is likely to expand in the molybdenum-99 market, with a size of US$ 407 million.
● By 2033, the molybdenum-99 sector is likely to increase in Canada, with a size of US$ 255 million.
The expansion in the United Kingdom is anticipated to expand at an adequate CAGR of 3.8% by 2033.
● Based on the isotope application, the gamma camera segment led the market CAGR of 3.1% by 2033.
● Based on end users, the hospitals continue to dominate the sector during the forecast period, with a CAGR of 4.9%.
Key Strategies in the Industry
The demand for molybdenum-99 is fueled by improvements in medical technology. Manufacturers are coping with an increase in the number of medical procedures and a rise in the prevalence of conditions that call for medical imaging.
Regulatory, price and resource availability policies are other factors that have an impact on the market. The molybdenum-99 market is often quite dynamic and competitive, with many competitors vying to offer high-quality goods and services at possible cheap costs.
Key players
IBA
Sumitomo Corporation
Advanced Cyclotron Systems, Inc.
Siemens Healthineers
Recent Developments
The United States Nuclear Regulatory Commission (NRC) approved a new regulation in 2019 that permits manufacturers of medicinal isotopes to use reactors without NRC licenses. With the use of reactors exempt from the strict NRC regulations, this new rule is anticipated to lower the price of molybdenum-99.
The molybdenum-99 market saw the entry of many new providers in 2019, including Nordion, NTP Radioisotopes, and the Australian Nuclear Science and Technology Organization. It is anticipated that the entry of these new providers boosts market competitiveness and aid in price reduction.
Argonne National Laboratory was given a US$ 25 million contract by the US Department of Energy (DOE) in 2019 to create a brand-new technique for separating molybdenum-99 from other isotopes. This new technique is anticipated to be more economical and effective than conventional techniques.
Key Segments
By Isotopic Application:
SPECT
Gamma Camera
By End User:
Hospitals
Diagnostic Centers
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
0 notes
Text
Harnessing Meitnerium's Potential in Sustainable Development Initiatives
The Meitnerium market, an intriguing segment within the realm of chemical elements, holds promise for significant growth and exploration from 2023 to 2031. As scientific endeavors continue to unravel the mysteries of elemental chemistry and nuclear physics, Meitnerium emerges as a fascinating subject of study and potential applications.
Meitnerium, with the atomic number 109 and the symbol Mt, is a synthetic element produced through nuclear reactions in laboratories. As a transactinide element, Meitnerium exhibits properties that are yet to be fully understood, making it a subject of intense scientific research and inquiry.
In 2022, the global industry was valued at US$46.8 thousand. It is forecasted to grow at a compound annual growth rate (CAGR) of 7.9% from 2023 to 2031, reaching US$92.9 thousand by the end of 2031.
Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85630
Market Segmentation:
By Service Type: Research & Development, Analytical Services, Consulting
By Sourcing Type: Laboratory Synthesis, Nuclear Reactors
By Application: Nuclear Physics Research, Material Science, Isotope Labeling, Others
By Industry Vertical: Scientific Research Institutions, Nuclear Facilities, Universities, Others
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Regional Analysis:
North America and Europe lead the Meitnerium market, boasting advanced research facilities, academic institutions, and nuclear research centers.
Asia Pacific is witnessing growing investments in scientific research and development, contributing to the expansion of the Meitnerium market in the region.
Market Drivers and Challenges:
Drivers:
Advancements in nuclear physics and particle accelerators, growing interest in transactinide elements, potential applications in materials science and nuclear medicine, and collaborative research efforts.
Challenges:
Limited availability of Meitnerium due to its synthetic nature, high costs associated with research and synthesis, safety and regulatory concerns, and competition for research funding.
Market Trends:
Exploration of Meitnerium's properties and behavior in extreme environments.
Applications in isotope labeling for biomedical research and nuclear medicine.
Collaborative international research projects aimed at synthesizing and studying Meitnerium isotopes.
Future Outlook:
The future of the Meitnerium market lies in continued scientific exploration and innovation. As researchers delve deeper into the properties and potential applications of Meitnerium and other transactinide elements, new insights and discoveries are anticipated, shaping the course of fundamental science and technology.
Key Market Study Points:
Synthesis and characterization of Meitnerium isotopes and their decay properties.
Applications in nuclear physics experiments, including superheavy element research and nuclear reactions.
Safety protocols and regulatory frameworks governing the handling and experimentation of synthetic elements.
Collaborative efforts and international partnerships in nuclear research and scientific exploration.
Competitive Landscape:
The Meitnerium market is characterized by collaboration and knowledge-sharing among scientific institutions, research laboratories, and academic organizations. While there may not be traditional competition in the commercial sense, scientific achievements and discoveries drive the advancement of knowledge and understanding in the field.
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=85630<ype=S
Recent Developments:
Synthesis of new Meitnerium isotopes with longer half-lives and unique properties.
Advancements in experimental techniques for studying superheavy elements.
Collaborative efforts to explore the potential applications of Meitnerium in materials science, nuclear medicine, and beyond.
About Transparency Market Research
Transparency Market Research, a global market research company registered in Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
0 notes
Text
Liquid Scintillation Analyzer Market Future News and Forecast by 2024-2032
The Reports and Insights, a leading market research company, has recently releases report titled “Liquid Scintillation Analyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Liquid Scintillation Analyzer Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the Liquid Scintillation Analyzer Market?
The global liquid scintillation analyzer market size reached US$ 1.6 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 2.4 billion in 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.
What are Liquid Scintillation Analyzer?
A liquid scintillation analyzer is a precise tool used to detect and quantify radioactivity in liquid samples. It operates by combining the liquid sample with a scintillation cocktail, which emits light upon exposure to radiation from the sample. Photomultiplier tubes detect this light, and the resulting signals are analyzed to determine the radioactivity level. These analyzers are widely employed in nuclear medicine, environmental monitoring, and research laboratories for applications like radiocarbon dating, pharmaceutical research, and managing radioactive waste.
Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/1910
What are the growth prospects and trends in the Liquid Scintillation Analyzer industry?
The liquid scintillation analyzer market growth is driven by various factors and trends. The liquid scintillation analyzer market is experiencing growth driven by rising demand for precise detection of radioactivity across various sectors. These analyzers find extensive application in nuclear medicine, environmental monitoring, and research laboratories for tasks like radiocarbon dating, pharmaceutical research, and handling radioactive waste. Market expansion is propelled by technological advancements, enhancing the sensitivity and effectiveness of these analyzers, alongside increasing awareness about radiation safety. Moreover, the growing necessity for monitoring radioactivity levels in both environmental and healthcare contexts contribute to market growth. Hence, all these factors contribute to liquid scintillation analyzer market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
By Product Type:
Benchtop Liquid Scintillation Analyzers
Portable Liquid Scintillation Analyzers
By Detector Type:
Photomultiplier Tubes (PMT)
Silicon Photomultipliers (SiPM)
By Application:
Radiometric Analysis
Environmental Monitoring
Drug Discovery and Development
Clinical Research
Forensic Science
Others
By End-Use:
Pharmaceutical and Biotechnology Companies
Research Institutes and Academic Centers
Environmental Monitoring Agencies
Nuclear Power Plants
Others
Market Segmentation By Region:
North America:
United States
Canada
Europe:
Germany
The U.K.
France
Spain
Italy
Russia
Poland
BENELUX
NORDIC
Rest of Europe
Asia Pacific:
China
India
Japan
South Korea
Australia
New Zealand
ASEAN
Rest of Asia Pacific
Latin America:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa:
Saudi Arabia
United Arab Emirates
South Africa
Egypt
Israel
Rest of MEA.
Who are the key players operating in the industry?
The report covers the major market players including:
PerkinElmer Inc.
Hidex
Beckman Coulter, Inc.
LabLogic Systems Ltd.
Hitachi Aloka Medical, Ltd.
Lumex Instruments
Berthold Technologies GmbH & Co. KG
Scintica Instrumentation Inc.
Packard Bioscience
Eberbach Corporation
Tri-Carb
LabLogic
Zinsser Analytic
Wallac
Canberra Industries
View Full Report: https://www.reportsandinsights.com/report/Liquid Scintillation Analyzer-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
Reports and Insights Business Research Pvt. Ltd.
1820 Avenue M, Brooklyn, NY, 11230, United States
Contact No: +1-(347)-748-1518
Email: [email protected]
Website: https://www.reportsandinsights.com/
Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/
Follow us on twitter: https://twitter.com/ReportsandInsi1
#Liquid Scintillation Analyzer Market share#Liquid Scintillation Analyzer Market size#Liquid Scintillation Analyzer Market trends
0 notes
Text
Europe Radiology Services Market Will Grow At Highest Pace Owing To Increasing Adoption Of Advanced
Radiology services involve the use of medical imaging to diagnose and monitor diseases, along with other procedures such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine including positron emission tomography (PET), and X-ray to produce images of the patient's internal body and prevent disease. The radiology services provide high resolution images of internal anatomy and physiology functioning of the human body. It has advantages such as painless, non-invasive, and easy to perform. The growing prevalence of chronic diseases such as cancer, cardiac disorders, and neurological diseases has fueled the demand for advanced medical imaging modalities in the Europe region.
The Global Europe Radiology Services Market Size Is Estimated To Be Valued At US$ 12.25 Bn In 2024 And Is Expected To Exhibit A CAGR Of 12.% Over The Forecast Period 2024-2031.
Key Takeaways
Key players operating in the Europe Radiology Services are Siemens Healthineers, Ge Healthcare, Canon Medical Systems, Carestream Health, Hitachi Medical, Hologic, Shimadzu, Fujifilm Holdings, Samsung Medison, Philips Healthcare. Key players are focused on mergers and acquisitions to expand their product portfolio and geographic presence. For instance, in 2021, Siemens Healthineers acquired Varian Medical Systems to enhance its radiation oncology business.
The demand for radiology services is growing owing to increasing prevalence of chronic diseases such as cancer, cardiac disorders, and neurological diseases. According to WHO, over 3.7 million new cancer cases and 1.9 million cancer deaths were estimated in Europe in 2020. Moreover, rising healthcare expenditure and government initiatives for improving healthcare infrastructure is also fueling the demand of radiology services across Europe.
Technological advancements in the radiology modalities such as quicker imaging, enhanced image quality, lower radiation dose, and integration of AI are propelling the Europe radiology services market. For example, Philips introduced Incisive CT imaging platform with speed and accuracy for complex cardiac and pulmonary scans in 2020.
Get more insights on this topic: https://www.pressreleasebulletin.com/europe-radiology-services-market-trend-size-and-demand/
#Europe Radiology Services Market Trend#Europe Radiology Services Market Growth#Europe Radiology Services Market Analysis#Europe Radiology Services Market Size
0 notes
Text
Emerging Tech Innovations in Neuroradiology – What Experts Have To Say
According to a neuroradiologist-nuclear medicine physician, one of the few in the world, the brand of neuroradiology is witnessing significant changes and shifts to cutting-edge technology. Recently, the national trend indicated a major boost in healthcare investment, primarily testing diagnostic radiology testing capabilities like MRI and CT scans.
Also recently, the investments made into CT scan and MRI technology have resulted in significant upgrades in patient care provided by the leading health centers and medical institutes. The leading neuroradiologist who is also a major nuclear medicine physician, David Douglas, there is immense scope for improvement with new medical imaging capabilities breaking into the field.
Based on current findings, the FDA and European clearance granted the use of the world’s first photon-counting CT, also known as a PCCT scanner. It was a significant breakthrough in the CT imaging field because the technology-enabled remarkable resolution improvements in the imaging results.
The advanced resolutions with clearer and more comprehensible visual cues were extensively appreciated by neuroradiologists and diagnostic experts. Douglas notes that the use of a PCCT scanner was also a big leap forward for CT imaging because it offers higher resolution with a lower radiation dose when compared to conventional CT practices.
The scientific evidence points towards the painstaking process that led to this groundbreaking technological innovation, which lasted nearly 15 years before the first active use was applauded. It was Siemens Healthineers that launched the world’s first CT scanner with PCCT technology.
Douglas, who has active medical licenses for California and Florida, has performed over 600 interventional radiology procedures. He is also touted as one of the most technical, skilled, and experienced diagnostic radiology professionals in the US.
To date, Douglas has performed over 250,000 interpretations and examinations CT scans, MRI scans, PET scans, X-ray reports, and ultrasounds. He recently shared his strong interest in the development of bedside imaging capabilities using POCUS, or point-of-care ultrasonography.
The article by the New England Journal of Medicine states that POCUS enables bedside clinical treatment of patients, allowing the healthcare provider to immediately interpret and integrate clinical imaging results. The imaging technology is seamlessly advancing as the modality’s applications increase in the management, treatment, and monitoring of critically ill virus patients.
Following COVID-19, medical professionals and scientific experts were exploring avenues for more compact, portable, and quick interpretation imaging modalities based on CT scan capabilities. Consequently, they endeavored to develop and test POCUS, which resulted in time-efficient and accurate diagnosis for critical monitoring applications.
The slow yet steady growth of the POCUS tech has ensured small, portable, and cost-effective ultrasound machines, albeit there is ongoing development to make the bedside imaging facility accessible to other nations.
In the opinion of Douglas, maturing technologies like artificial intelligence (AI), machine learning (ML), and deep learning (DL), underscore the need to improve and optimize clinical processes and decision-making. Through the use of AI, radiologists are equipped with the tools and knowledge to optimize workflows, leading to accurate and more reliable diagnoses in less time.
0 notes
Text
Radiation Protection Apparels to Witness Phenomenal Growth from 2024 to 2030|
According to HTF Market Intelligence, theGlobal Radiation Protection Apparels market to witness a CAGR of % during forecast period of 2024-2030. Global Radiation Protection Apparels Market Breakdown by Application (Medical Imaging, Radiation Oncology, Nuclear Medicine, Others) by Type (Lead Aprons, Lead Gloves, Lead Glasses, Others) by Sales Channel (Online, Offline) by End User (Healthcare Sector, Industrial Sector, Defence and Military Services, Others) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Radiation Protection Apparels market size is estimated to increase by USD 602.25 Million at a CAGR of % from 2024 to 2030. Currently, market value is pegged at USD 441.69Million.
Get Detailed TOC and Overview of Report @
Clothing or gear designed to shield individuals from exposure to harmful radiation, often used in medical or industrial settings.
Some of the key players profiled in the study are 3M Company (United States), Bar-Ray Products, Inc. (United States), Burlington Medical Supplies (United States), Infab Corporation (United States), Anetic Aid Limited (United Kingdom), MAVIG GmbH (Germany), Protech Medical (France), Kiran X-ray (India), AADCO Medical, Inc. (United States), AmRay Medical (Ireland), Cablas (Italy).
Book Latest Edition of Global Radiation Protection Apparels Market Study @ https://www.htfmarketintelligence.com/buy-now?format=1&report=4776
About Us:
HTF Market Intelligence is a leading market research company providing end-to-end syndicated and custom market reports, consulting services, and insightful information across the globe. HTF MI integrates History, Trends, and Forecasts to identify the highest value opportunities, cope with the most critical business challenges and transform the businesses. Analysts at HTF MI focuses on comprehending the unique needs of each client to deliver insights that are most suited to his particular requirements.
Contact Us:
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Phone: +15075562445
[email protected]
0 notes
Text
Pre-Owned Medical Devices Market Outlook, Trends and Forecast 2024-2032
IMARC Group's report titled "Pre-Owned Medical Devices Market by Type (X-ray, Mammography Machines, CT Machines, MRI Machines, Ultrasound Machines, Nuclear Imaging and Medicine Devices, C-arm Devices), End User (Hospitals, Clinics), and Region 2024-2032", The global pre-owned medical devices market size reached US$ 7.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.89% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/pre-owned-medical-devices-market/requestsample
Factors Affecting the Growth of the Pre-Owned Medical Devices Industry:
Cost-effectiveness:
Pre-owned medical devices are available at a fraction of the cost of new equipment. Healthcare facilities, especially those operating on tight budgets, find pre-owned devices to be a cost-effective alternative that allows them to acquire necessary equipment without significant financial strain. Investing in pre-owned medical devices enables healthcare providers to minimize their capital expenditure while still acquiring high-quality equipment. This cost-saving measure allows healthcare facilities to allocate resources to other critical areas, such as patient care, staff training, and infrastructure development.
Increasing Demand for Healthcare Services:
With the growing population and changing demographics, there is a need for the expansion of healthcare facilities, including hospitals, clinics, and diagnostic centers. Acquiring pre-owned medical devices enables newly established or expanding facilities to equip themselves quickly and affordably to meet the increasing demand for healthcare services. In regions with limited resources or underserved communities, the demand for healthcare services often outstrips the availability of essential medical equipment. Pre-owned medical devices offer a practical solution by providing access to quality equipment at a lower cost, thereby enabling healthcare providers to address the unmet needs of their patients.
Technological Advancements:
Innovations in medical technology are leading to shorter product life cycles for medical devices. As newer and more advanced equipment is becoming available, healthcare facilities often upgrade their existing devices, creating a steady supply of pre-owned medical devices in the market. Technological advancements are contributing to the refurbishment process, allowing pre-owned medical devices to undergo thorough testing, repairs, and upgrades. This ensures that refurbished equipment meets or exceeds industry standards for quality, performance, and safety, making it an attractive option for healthcare providers seeking cost-effective alternatives to new equipment.
Leading Companies Operating in the Global Pre-Owned Medical Devices Industry:
Advanced Ultrasound Systems
Block Imaging International Inc.
Canon Medical Systems Corporation (Canon Inc.)
EverX Pty Ltd
GE HealthCare Technologies Inc (General Electric Company)
Integrity Medical Systems Inc.
Koninklijke Philips N.V.
Probo Medical LLC
Siemens Healthineers AG (Siemens AG)
Soma Tech Intl
Pre-Owned Medical Devices Market Report Segmentation:
By Type:
X-ray
Mammography Machines
CT Machines
MRI Machines
Ultrasound Machines
Nuclear Imaging and Medicine Devices
C-arm Devices
CT machines represent the largest segment due to their widespread use in diagnostic imaging, their high initial cost making pre-owned options attractive, and the constant technological advancements leading to frequent upgrades and replacements in healthcare facilities.
By End User:
Hospitals
Clinics
Hospitals account for the majority of the market share as they have a higher demand for a wide range of medical devices, including both general equipment and specialized devices, to cater to the diverse healthcare needs of their patient populations.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America enjoys the leading position in the pre-owned medical devices market owing to a well-established healthcare infrastructure high adoption rate of advanced medical technologies, and stringent regulatory standards promoting the refurbishment and resale of medical equipment.
Global Pre-Owned Medical Devices Market Trends:
Regulatory bodies are recognizing the safety and efficacy of refurbished medical devices, leading to the rising acceptance and adoption of pre-owned equipment by healthcare facilities worldwide.
The refurbishment and reuse of pre-owned medical devices align with sustainability initiatives, as they reduce electronic waste and promote resource conservation, thereby contributing to the growth of the market.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
0 notes
Text
Women’s History Month March 2024
Discover a bouquet of women botanists and plant scientists from history!
Barbara McClintock
Why does Native American flint corn (Zea mays) often have a multicoloured mosaic pattern of kernel colours? The biological answer is transposons or “jumping genes”! Dr. Barbara McClintock (June 16, 1902 – September 2, 1992) was the American cytogeneticist who discovered that certain genetic loci can change position on chromosomes, a phenomenon called “transposition”, using multicoloured corn as the model organism between 1948 and 1950. McClintock courageously pursued her calling as a biologist despite societal attitudes discriminating against women in scientific careers. She went on to win the 1983 Nobel Prize for Physiology or Medicine for her work on transposons.
Janaki Ammal
The first woman to earn a PhD in botany at a university in the USA was actually from India! Janaki Ammal (4 November 1897 – 7 February 1984) was born in Kerala, India, to a family of civil servants. She travelled to the USA via scholarships for Asian students and earned both a Masters degree and PhD from the University of Michigan by 1931. At the John Innes Centre in the UK, she co-authored the Chromosome Atlas of Cultivated Plants (1945). Later in her career she worked on breeding superior varieties of sugarcane and eggplant in her home country.
Estelle Leopold
A botanist interested in both the past and the future of plant life, Estelle Leopold (January 8, 1927 – February 25, 2024) pioneered the use of fossilised pollen and spores to document environmental changes over vast time periods. Her research uncovered connections between climate change and evolution plus extinction of plant species, including trends of the central regions of continents experiencing more species turnover than coastal areas. Her work as a conservationist led to the protection of the Florissant Fossil Beds National Monument in Colorado, and she also helped prevent the building of dams in the Grand Canyon as well as oil shale development and the transport of nuclear waste in the Pacific Northwest.
#womeninscience#womenshistorymonth#plantscience#botany#barbaramcclintock#scientist#womenscientists#botanists#janakiammal#estelleleopold#history#inspiringwomen#WomenInSTEM#womeninplantscience#PlantBiology
#katia plant scientist#botany#plant biology#plants#plant science#women in science#women in stem#stem#stemblr#science#plant scientist#female scientists#women scientists#womens history#international women's day#women's history month#women in plant biology#women in biology#biologist#researchers#academics
1 note
·
View note
Text
MSC Medical Imaging Technology | M.Sc in Cardiac Care - SIHS Pune
The Master of Science (MSc) in Medical Imaging Technology program at Symbiosis Institute of Health Sciences, Pune, is designed to equip students with the knowledge and skills needed to excel in the field of medical imaging. The program covers a wide range of topics, including radiography, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine imaging.
Students enrolled in the MSc Medical Imaging Technology program at Symbiosis Institute of Health Sciences, Pune, have access to state-of-the-art facilities and equipment, allowing them to gain hands-on experience in various imaging techniques. The institute also has collaborations with leading healthcare organizations, providing students with opportunities for internships and practical training.
The faculty at Symbiosis Institute of Health Sciences, Pune, are experienced professionals in the field of medical imaging, ensuring that students receive a high-quality education that is relevant to the latest industry trends and practices. Graduates of the MSc Medical Imaging Technology program are well-equipped to pursue careers in hospitals, diagnostic centers, research institutions, and other healthcare settings, where they can make a meaningful impact on patient care. Kindly visit https://www.sihs.edu.in/msc-medical-technology to know more.
0 notes
Text
Evaluating Market Size and Growth Potential in Diagnostic Imaging Market
Market Overview –
The diagnostic imaging market is anticipated to reach USD 49.66 billion by 2032, growing at a CAGR of 4.7% over the forecast period 2023-2032.
The Diagnostic Imaging Market encompasses a wide range of medical imaging technologies used to visualize internal body structures and diagnose various medical conditions. These imaging modalities include X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT).
The diagnostic imaging market is thriving, propelled by advancements in medical imaging technologies. Medical imaging plays a crucial role in disease detection, diagnosis, and treatment planning. With continuous innovation, such as AI integration and portable imaging devices, the market is witnessing sustained growth, meeting the increasing demand for accurate and efficient diagnostic solutions.
In recent years, the diagnostic imaging market has experienced significant growth globally due to several factors. Firstly, there has been increasing demand for diagnostic imaging procedures driven by factors such as aging populations, rising prevalence of chronic diseases, and advancements in imaging technology. Key players in this market include medical device manufacturers, imaging equipment suppliers, healthcare providers, and research institutions, collaborating to develop and commercialize innovative imaging solutions.
Moreover, advancements in imaging technology have led to the development of new imaging modalities with improved resolution, speed, and diagnostic accuracy. These advancements enable earlier detection of diseases, more precise treatment planning, and better monitoring of treatment response, ultimately leading to improved patient outcomes.
Additionally, there is growing interest in personalized imaging approaches tailored to individual patient characteristics, such as genetic profiles, disease stage, and treatment history. Personalized imaging techniques enable healthcare providers to optimize imaging protocols and treatment strategies based on each patient's unique needs, enhancing the efficacy and safety of medical imaging procedures.
Overall, the diagnostic imaging market presents opportunities for growth and innovation as it continues to evolve with advancements in technology and increasing demand for diagnostic imaging services worldwide. Efforts to develop new imaging modalities, improve imaging quality, and expand access to imaging services are essential for advancing healthcare practices and improving patient care.
Market Segmentation –
The global diagnostic imaging market has been segmented on the basis of product, source, and application.
Based on product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other products
The market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applications
The end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.
Regional Analysis –
Regional analysis of the diagnostic imaging market is essential for understanding the adoption, trends, and dynamics of imaging modalities across different geographic regions. Diagnostic imaging plays a crucial role in healthcare by enabling the visualization of internal body structures for diagnosis, monitoring, and treatment planning. Factors such as healthcare infrastructure, reimbursement policies, and prevalence of diseases influence the demand for various imaging technologies in each region.
Developed regions like North America and Europe often lead in the adoption of advanced imaging modalities such as MRI, CT scans, and PET scans due to well-established healthcare systems, high healthcare spending, and early adoption of innovative medical technologies. In contrast, emerging economies in Asia-Pacific and Latin America are witnessing increasing demand for diagnostic imaging, driven by factors such as rising healthcare expenditure, improving access to healthcare services, and growing prevalence of chronic diseases. Additionally, variations in regulatory frameworks and cultural attitudes towards healthcare impact market dynamics and adoption rates across regions.
Conducting a comprehensive regional analysis enables stakeholders to identify market opportunities, tailor their marketing strategies, and address region-specific challenges such as regulatory compliance and market access. By understanding regional nuances, companies can optimize their market penetration efforts and better serve the diagnostic imaging needs of healthcare providers and patients worldwide.
Key Players –
The Diagnostic imaging company profiles include Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Carestream Health, Esoate SpA, GE Healthcare, Toshiba Medical Systems Corporation, FUJIFILM Holdings Corporation, Siemens Healthcare Private Limited, Hitachi Medical Systems, Hologic Inc., and Shimadzu Corporation.
Related Reports –
Macrolide Antibiotics
Spinal Traction
Performance Enhancing Drugs
Vasectomy
For more information visit at MarketResearchFuture
#Diagnostic Imaging Market#Diagnostic Imaging Market Size#Diagnostic Imaging Market Share#Diagnostic Imaging Market Growth#Diagnostic Imaging Market Trends
0 notes
Last Seen Blogs
